Tiziana Life Sciences Investor Presentation — August 2020

An Innovative Platform in Oral, Nasal and Inhalation for Monoclonal Antibody Administration Proprietary inhalation delivery of anti -IL-6R mAb for COVID -19 treatment Advanced clinical programs in Crohn ’s Disease, progressive Multiple Sclerosis, and Hepatocellular Carcinoma Augu